Nosocomial Acinetobacter pneumonia

被引:48
|
作者
Luna, Carlos M. [1 ]
Aruj, Patricia K. [1 ]
机构
[1] Univ Buenos Aires, Hosp Clin, Dept Internal Med, Div Pulm Dis, Buenos Aires, DF, Argentina
关键词
Acinetobacter; nosocomial pneumonia; multi-drug resistant; ventilator-associated pneumonia;
D O I
10.1111/j.1440-1843.2007.01147.x
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Acinetobacter spp. (A. baumannii is the prevalent genomic species, but others may cause infection) has become an increasingly important cause of nosocomial pneumonia, particularly in mechanically ventilated patients (VAP). This organism has intrinsic resistance to some antimicrobials but easily acquires resistance to many others; Acinetobacter spp. can survive for long periods of time in the environment. All of these characteristics have contributed to protracted outbreaks associated with significant morbidity and mortality. High rates of colonization are found in debilitated hospitalized patients. Infecting or colonizing organisms in nosocomial infections are more likely to be from cross-transmission or from the hospital environment than from endogenous sources. VAP caused by Acinetobacter spp. is emerging as a prominent hospital complication. The incidence of this microorganism varies from site to site, but it is the second commonest aetiological agent among the gram-negative bacteria. Longer periods of hospitalization, longer time on mechanical ventilation and prior use of antibiotics are the recognized factors increasing the risk of VAP due to Acinetobacter spp. Treatment needs to clearly differentiate infection from colonization, and the agents with the most antimicrobial activity are imipenem/cilastatin, amikacin, colistin, ampicillin/sulbactam and tigecycline. Monotherapy can be adequate if the patient does not have significant comorbidities. Infection control procedures have a major role to play in preventing transmission of this microorganism. Emphasis on initial control measures should, however, be on strict isolation of infected or colonized patients to limit dissemination of outbreak strains in the environment. The variety of potential sources of contamination with Acinetobacter spp. in the hospital environment makes control of these outbreaks one of the more difficult challenges. Persistence of Acinetobacter spp. in the environment provides ample opportunities for contamination of patients and staff and may explain continuing long-term outbreaks.
引用
收藏
页码:787 / 791
页数:5
相关论文
共 50 条
  • [41] A Trial of Aerosolized Colistin for the Treatment of Nosocomial Pneumonia Due to Multidrug-Resistant Acinetobacter baumannii.
    Kim, D. G.
    Park, S. H.
    Park, H. R.
    Jung, K. S.
    Kim, C. H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [42] Acinetobacter baumannii nosocomial pneumonia: is the outcome more favorable in non-ventilated than ventilated patients?
    Yang, Ya-Sung
    Lee, Yi-Tzu
    Huang, Tsai-Wang
    Sun, Jun-Ren
    Kuo, Shu-Chen
    Yang, Chin-Hsuan
    Chen, Te-Li
    Lin, Jung-Chung
    Fung, Chang-Phone
    Chang, Feng-Yee
    BMC INFECTIOUS DISEASES, 2013, 13
  • [43] A pharmacodynamic simulation to evaluate tigecycline in treatment of nosocomial pneumonia caused by multidrug-resistant Acinetobacter baumannii
    Ni, Wen-tao
    Liang, Bei-bei
    Cai, Yun
    Liu, Yin-ping
    Bai, Nan
    Cui, Jun-chang
    Wang, Rui
    PAKISTAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2014, 27 (03) : 463 - 467
  • [44] Nosocomial pneumonia:: therapy
    Ewig, S.
    Ostendorf, U.
    Mueller, E.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2006, 131 (48) : 2722 - 2725
  • [45] THE PATHOLOGY OF NOSOCOMIAL PNEUMONIA
    COALSON, JJ
    CLINICS IN CHEST MEDICINE, 1995, 16 (01) : 13 - 28
  • [46] NOSOCOMIAL PNEUMONIA RISKS
    MEYER, C
    AMERICAN JOURNAL OF NURSING, 1992, 92 (11) : 11 - +
  • [47] Cefiderocol for nosocomial pneumonia
    McConnell, John
    LANCET INFECTIOUS DISEASES, 2019, 19 (12): : 1290 - 1290
  • [48] An unusual nosocomial pneumonia
    Baddi, L
    Ray, D
    CHEST, 2002, 122 (03) : 1077 - 1079
  • [49] NOSOCOMIAL PNEUMONIA - REPLY
    NIELSEN, SL
    RODER, B
    MAGNUSSEN, P
    ENGQUIST, A
    FRIMODTMOLLER, N
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1992, 24 (04) : 556 - 556
  • [50] Management of Nosocomial Pneumonia
    Connor, Kathryn A.
    AACN ADVANCED CRITICAL CARE, 2018, 29 (01) : 5 - 10